Kono Yusuke, Saito Hiroaki, Murakami Yuki, Shishido Yuji, Kuroda Hirohiko, Matsunaga Tomoyuki, Yamamoto Manabu, Fukumoto Yoji, Osaki Tomohiro, Ashida Keigo, Fujiwara Yoshiyuki
Division of Surgical Oncology, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, 683-8504, Japan.
Surg Today. 2019 Mar;49(3):206-213. doi: 10.1007/s00595-018-1724-x. Epub 2018 Oct 13.
Inflammation, together with immune and nutritional status, are associated with the progression of various cancer types. We evaluated the prognostic significance of the postoperative ratio (post-CLR) of the maximum C-reactive protein value (post-CRP) to the minimum peripheral lymphocyte count (post-LC) in patients with gastric cancer (GC).
The subjects of this retrospective study were 227 patients who underwent curative surgery for histopathologically diagnosed gastric adenocarcinoma.
The 5-year overall survival (OS) rates differed significantly between the post-CLR (≥ 152.6) group and the post-CLR (< 152.6) group for all patients (45.0% vs. 68.4%, respectively; P < 0.001). The 5-year disease-specific survival (DSS) rates were also significantly related to post-CLR for all patients, (80.6% vs. 64.3% for the post-CLR and the post-CLR groups, respectively; P = 0.002). Among patients without infectious complications, the CLR affected both the 5-year OS rate (48.4% vs. 69.2% for the post-CLR and the post-CLR groups, respectively; P = 0.006) and the 5-year DSS rate (80.2% vs. 67.0% for the post-CLR and the post-CLR groups, respectively; P = 0.027). Multivariate analysis revealed that post-CLR was an independent prognostic indicator for both the OS and DSS of all patients.
Our finding show that the post-CLR can help predict the prognosis of GC patients.
炎症与免疫及营养状况一起,与多种癌症类型的进展相关。我们评估了胃癌(GC)患者术后最大C反应蛋白值(术后CRP)与最低外周淋巴细胞计数(术后LC)的比值(术后CLR)的预后意义。
本回顾性研究的对象为227例经组织病理学诊断为胃腺癌并接受根治性手术的患者。
所有患者中,术后CLR(≥152.6)组与术后CLR(<152.6)组的5年总生存率(OS)差异显著(分别为45.0%和68.4%;P<0.001)。所有患者的5年疾病特异性生存率(DSS)也与术后CLR显著相关(术后CLR组和术后CLR组分别为80.6%和64.3%;P = 0.002)。在无感染并发症的患者中,CLR影响5年OS率(术后CLR组和术后CLR组分别为48.4%和69.2%;P = 0.006)和5年DSS率(术后CLR组和术后CLR组分别为80.2%和67.0%;P = 0.027)。多因素分析显示,术后CLR是所有患者OS和DSS的独立预后指标。
我们的研究结果表明,术后CLR有助于预测GC患者的预后。